Yan Ji

Ribociclib plus Endocrine Therapy in Early Breast Cancer

Dennis J. Slamon, Oleg Lipatov, Zbigniew Nowecki et al. · New England Journal of Medicine · 2024 · 357 citations

Medicine, Oncology, Pharmacology +15

Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival

Dennis J. Slamon, Patrick Neven, Stephen Chia et al. · Annals of Oncology · 2021 · 278 citations · Full text

Medicine, Oncology, Pharmacology +17

Disruption of Nrf2 Enhances Upregulation of Nuclear Factor‐<i>κ</i>B Activity, Proinflammatory Cytokines, and Intercellular Adhesion Molecule‐1 in the Brain after Traumatic Brain Injury

Wei Jin, Handong Wang, Wei Yan et al. · Mediators of Inflammation · 2008 · 171 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours

Jordi Rodón, Guillem Argilés, Roisín M. Connolly et al. · British Journal of Cancer · 2021 · 160 citations · Full text

Medicine, Oncology, Pharmacology +6

Anti-inflammatory Action of Pterostilbene Is Mediated through the p38 Mitogen-Activated Protein Kinase Pathway in Colon Cancer Cells

Shiby Paul, Agnes M. Rimando, Hong Jin Lee et al. · Cancer Prevention Research · 2009 · 151 citations · Full text

Medicine, Oncology, Pharmacology +17